Impact Compounding

Katie is a part-owner, Operations Manager and Compounding Technician at Impact Compounding in Tipp City, Ohio, where she focuses on prescription compounding, bioidentical hormone replacement therapy, pharmacy operations, marketing and provider relations. She has been featured on PCCA’s Tech Talk Podcast and was honored as PCCA’s 2025 USA Compounding Technician of the Year.

PCCA

The leader of our innovations in base technology, Daniel joined PCCA in 2011 and is currently vice president of research and development. He has more than 20 years of hands-on experience in preformulation/formulation/reformulation of a variety of dosage forms, specializing in pharmaceutical solids, liquids and semisolids. He has worked extensively on the development of novel techniques for skin-permeation enhancement.

ScriptWorks Pharmacy

As a third-generation compounding pharmacist, Matt is Vice President of ScriptWorks Pharmacy in Walnut Creek, California. He enjoys the opportunity to merge his passion for pharmacy and veterinary medicine by assisting local veterinarians with some of their most difficult infectious disease cases.[JF3.1] Matt received PCCA’s George Roentsch New Innovator Award in 2025.

PCCA

Deborah became a PCCA clinical compounding pharmacist in 2009. Her areas of interest include veterinary compounding, hormone replacement, pain/wound care, pediatrics and dermatology. She frequently speaks at PCCA symposiums and is a Fellow of the American College of Veterinary Pharmacists. Deborah is a UNC Chapel Hill pharmacy graduate and is licensed in North Carolina.

PCCA

Sebastian joined PCCA as a Clinical Compounding Pharmacist in 2011, having practiced nonsterile compounding for 11 years in North Vancouver, British Columbia, Canada. He works with both the U.S. and Canadian education teams, training pharmacists, technicians and students. Sebastian helps community pharmacies and health systems to achieve regulatory compliance and implement best practices.[JF4.1] He has collaborated on projects with the LDN Research Trust and been a guest on the LDN Radio Show, thanks to his interest in therapeutic applications for low-dose Naltrexone.

HatchRx Compounding Pharmacy

Isha’s pharmacy in Long Island, New York, operates on the idea that modern innovation and personalized medicine should work hand-in-hand to meet each person’s unique health needs. Focused on patient education, she strives to empower patients to take control of their health through customized solutions. Isha received PCCA’s George Roentsch New Innovator Award in 2024.

PCCA

Beau joined PCCA in January 2015 as a full-time clinical compounding pharmacist, after serving part-time for the previous year and a half. Many members will recognize him as a speaker and lab instructor from PCCA training events. Previously, Beau worked as a compounding pharmacist for 15 years, including 8 years as the pharmacist in charge of Nucara Compounding Pharmacy in Austin, Texas. He is a graduate of the University of Mississippi and taught pharmacology at William Carey College in Gulfport, Mississippi.

PCCA

Since 2000, Tricia has been a full-time clinical compounding pharmacist at PCCA, assisting pharmacists in the US and Canada and speaking at PCCA symposiums. Tricia’s areas of interest include pediatric compounding (including autism treatment), women’s health, GI health and pain management. She is a University of Houston College of Pharmacy graduate and completed a PCCA PharmD Residency.

National Community Pharmacists Association

Since 2011, Doug has served as CEO of the National Community Pharmacists Association (NCPA), which represents nearly 19,400 pharmacy small businesses. He is a licensed pharmacist in Oklahoma, Virginia and Texas, and previously practiced in a variety of community pharmacy settings, including his own family’s pharmacy. Doug is widely quoted by media as an industry expert on community pharmacy practice issues.

Koshland Pharm: Custom Compounding Pharmacy

Peter opened Koshland Pharm in 2009 in San Franscisco and is known for his passion for speaking about health topics to both medical and general audiences. Peter also advocates for our industry, consistently engaging in dialogue about regulatory standards, quality assurance and patient care. In 2025, Peter was honored as PCCA’s USA Compounding Pharmacist of the Year.

PCCA

Ranel became a PCCA a clinical compounding pharmacist in 2014. Prior to joining PCCA, she worked in retail pharmacy for three years and then operated a compounding-only pharmacy for more than four years. Her areas of interest include HRT for men and women, veterinary medicine, pain management and dermatology. She is a graduate of the Roseman University School of Pharmacy. 

PCCA

Before Matthew joined PCCA as a clinical compounding pharmacist in 2022, he was COO of Oakdell Pharmacy, where he specialized in infusion, long-term care, consulting and disease management. With a passion for patient care, Matthew is formerly a member of the NCPA Compounding Steering Committee and currently serves as a preceptor for pharmacy schools including The University of Texas College of Pharmacy, Duquesne and Xavier, among others. He also holds advanced certifications in sterile compounding and hormone replacement.